These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15289137)

  • 1. Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases.
    Umeda N; Ozaki H; Hayashi H; Oshima K
    Am J Ophthalmol; 2004 Aug; 138(2):270-9. PubMed ID: 15289137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations.
    Diehl S; Bruno R; Wilkinson GA; Loose DA; Wilting J; Schweigerer L; Klein R
    Pediatr Res; 2005 Apr; 57(4):537-44. PubMed ID: 15718372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colocalization of Tie2, angiopoietin 2 and vascular endothelial growth factor in fibrovascular membrane from patients with retinopathy of prematurity.
    Umeda N; Ozaki H; Hayashi H; Miyajima-Uchida H; Oshima K
    Ophthalmic Res; 2003; 35(4):217-23. PubMed ID: 12815197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
    J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubedown-1 (Tbdn-1) suppression in oxygen-induced retinopathy and in retinopathy of prematurity.
    Gendron RL; Good WV; Miskiewicz E; Tucker S; Phelps DL; Paradis H
    Mol Vis; 2006 Feb; 12():108-16. PubMed ID: 16518308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
    He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apelin in epiretinal fibrovascular membranes of patients with retinopathy of prematurity and the changes after intravitreal bevacizumab.
    Zhang Y; Jiang YR; Lu Q; Yin H; Tao Y
    Retina; 2013 Mar; 33(3):613-20. PubMed ID: 23296045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
    Ehlken C; Martin G; Lange C; Gogaki EG; Fiedler U; Schaffner F; Hansen LL; Augustin HG; Agostini HT
    Acta Ophthalmol; 2011 Feb; 89(1):82-90. PubMed ID: 19764912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma.
    Yavrouian EJ; Sinha UK; Rice DH; Salam MT; Gill PS; Masood R
    Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):985-91. PubMed ID: 18794445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detecting protein expression of EphrinB2 ligand and its receptor EphB4 in astrocytoma using confocal laser scanning microscopy].
    Xiao HL; Bian XW; Li ZP; Long ZY; Wang D
    Ai Zheng; 2004 Oct; 23(10):1161-5. PubMed ID: 15473927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
    Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
    Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
    Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
    Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
    Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
    J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.